An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

Please use this identifier to cite or link to this item: https://doi.org/10.1136/gut.52.5.671

DC Field	Value
dc.title	An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
dc.contributor.author	Wagner, A.
dc.contributor.author	Kellow, J.
dc.contributor.author	Lee, O.Y.
dc.contributor.author	Chang, F.Y.
dc.contributor.author	Thongsawat, S.
dc.contributor.author	Mazlam, M.Z.
dc.contributor.author	Yuen, H.
dc.contributor.author	Gwee, K.A.
dc.contributor.author	Bak, Y.T.
dc.contributor.author	Jones, J.
dc.date.accessioned	2014-12-17T08:54:23Z
dc.date.available	2014-12-17T08:54:23Z
dc.date.issued	2003
dc.identifier.citation	Wagner, A., Kellow, J., Lee, O.Y., Chang, F.Y., Thongsawat, S., Mazlam, M.Z., Yuen, H., Gwee, K.A., Bak, Y.T., Jones, J. (2003). An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52 (5) : 671-676. ScholarBank@NUS Repository. https://doi.org/10.1136/gut.52.5.671
dc.identifier.issn	00175749
dc.identifier.uri	http://scholarbank.nus.edu.sg/handle/10635/117556
dc.description.uri	http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1136/gut.52.5.671
dc.source	Scopus
dc.type	Article
dc.contributor.department	MEDICINE
dc.description.doi	10.1136/gut.52.5.671
dc.description.sourcetitle	Gut
dc.description.volume	52
dc.description.issue	5
dc.description.page	671-676
dc.description.coden	GUTTA
dc.identifier.isiut	000182176300012
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check